Literature DB >> 7626365

Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

B Cheung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7626365      PMCID： PMC483928          DOI： 10.1136/hrt.73.6.584-b

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  8 in total

1.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro.

Authors:  P Mäntymaa; O Vuolteenaho; M Marttila; H Ruskoaho
Journal:  Endocrinology       Date:  1993-09       Impact factor: 4.736

3.  The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man.

Authors:  C C Lang; A M Choy; K Turner; R Tobin; W Coutie; A D Struthers
Journal:  J Hypertens       Date:  1993-07       Impact factor: 4.844

4.  Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

Authors:  E Morita; H Yasue; M Yoshimura; H Ogawa; M Jougasaki; T Matsumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

5.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

6.  Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; H Tanaka; K Kikuta; H Sumida; H Kato; M Jougasaki; K Nakao
Journal:  Br Heart J       Date:  1994-12

7.  Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects.

Authors:  B M Cheung; J E Dickerson; M J Ashby; M J Brown; J Brown
Journal:  Clin Sci (Lond)       Date:  1994-06       Impact factor: 6.124

8.  Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide.

Authors:  M Kojima; N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.